Salesforce Ventures and Atlassian Ventures helped the pre-sales software developer boost its funding to $56m altogether.

The lottery ticket purchasing app provider said it saw record new user growth last month, as it secured funding from investors including Tegna and Circle K.

The past week's M&A exits included Genetirate, DataFleets and SightGlass Vision.

Osage University Partners has contributed to an oversubscribed series C round for Cyteir, which was led by RA Capital.

The healthcare engagement technology provider has received $12m in a round co-led by the Blue Cross Blue Shield-backed Blue Venture Fund.

The medical documentation tool developer has been acquired by Nuance Communications having raised $7.5m from investors including NewYork-Presbyterian.

The gas-to-hydrogen technology developer bagged $11.5m in a round co-led by Eni Next and backed by Mitsubishi Heavy Industries.

Q&A with Tiffine Wang, investment partner, MS&AD Ventures

Access Biotechnology returned for a round that will push Day One Biopharmaceuticals' paediatric drug candidate through a phase 2 study.

Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.